Trademark Alertz ®
Search
Trademark
Owner
Trademark: LONGAVO 2441832
Word
LONGAVO
ID
2441832
Trademark Type
WORD
Status
Accepted: Awaiting advertisement
Application Date
10 April 2024
Owner(s)
Teva Pharmaceuticals International GmbH
Service
IP Gateway Patent & Trade Mark Attorneys Pty Ltd
Goods and Services:
Class 5
:
Pharmaceutical preparations for the prevention and treatment of Alzheimer’s disease
;
pharmaceutical preparations for the prevention and treatment of depression
;
pharmaceutical preparations for the prevention and treatment of psychological disorders
;
pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy
;
pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders
;
pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome
;
pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders
;
pharmaceutical preparations for the prevention and treatment of osteoporosis
;
pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain
;
pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders
;
pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders
;
pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders
;
pharmaceutical preparations for the prevention and treatment of sexual dysfunction
;
pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids
;
pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder
;
pharmaceutical preparations for the prevention and treatment of aids-related disorders
;
pharmaceutical preparations that support, encourage and promote bone strength
;
pharmaceutical preparations that support, encourage and promote bone health
;
pharmaceutical preparations used in the treatment of bone disorders and bone diseases
;
pharmaceutical preparations, namely, injectable contraceptives
;
pharmaceutical preparations, namely, contraceptive preparations
;
pharmaceutical preparations, namely, fertility enhanceme
;
nt preparations
;
pharmaceutical preparations, namely, hormone replacement therapy preparations
;
pharmaceutical preparations for the treatment of cancer
;
pharmaceutical agents affecting the central nervous system
;
pharmaceutical agents affecting circulatory systems
;
pharmaceutical agents affecting sensory organs
;
pharmaceutical agents affecting urogenital organs
;
pharmaceutical agents affecting peripheral nervous system
;
pharmaceutical preparations for the treatment of neurological disorders